PELIZZARI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 1.210
EU - Europa 208
AS - Asia 90
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.512
Nazione #
US - Stati Uniti d'America 1.209
BE - Belgio 63
IT - Italia 58
CN - Cina 41
VN - Vietnam 29
UA - Ucraina 22
IE - Irlanda 21
DE - Germania 19
IN - India 13
GB - Regno Unito 9
IR - Iran 7
RU - Federazione Russa 5
CZ - Repubblica Ceca 3
EG - Egitto 2
RO - Romania 2
SE - Svezia 2
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
EU - Europa 1
FI - Finlandia 1
FR - Francia 1
NO - Norvegia 1
Totale 1.512
Città #
Chandler 172
Fairfield 134
Ashburn 123
Ann Arbor 111
Seattle 64
Brussels 63
Houston 58
Woodbridge 50
Wilmington 49
Cambridge 41
New York 34
Dong Ket 29
Beijing 27
Princeton 26
Dublin 21
San Diego 15
Redmond 14
Dearborn 13
Jacksonville 12
Ogden 11
Martignacco 9
Washington 8
Leawood 7
Ardabil 6
Augusta 4
Des Moines 4
San Mateo 4
Udine 4
Caserta 3
Jinan 3
Nanjing 3
Norwalk 3
Scafati 3
Trieste 3
Boardman 2
Brno 2
Cairo 2
Dallas 2
Edinburgh 2
Milan 2
Phoenix 2
Redwood City 2
Sagrado 2
Asti 1
Bangalore 1
Boston 1
Bucharest 1
Chengdu 1
Florence 1
Fuzhou 1
Grafing 1
Helsinki 1
Kunming 1
Langfang 1
Melfi 1
Mortegliano 1
Nanchang 1
Naples 1
Paris 1
Prague 1
Romans 1
Rutigliano 1
San Remo 1
Shenzhen 1
Toronto 1
Trento 1
Tuenno 1
Venezia 1
Wenzhou 1
Wuhan 1
Totale 1.176
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 125
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 102
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 95
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 93
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 83
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 82
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 82
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 78
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 68
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 61
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 60
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 53
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 40
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 40
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 38
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 36
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 34
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 33
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 32
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 30
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 30
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 29
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 23
Totale 1.593
Categoria #
all - tutte 5.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 15 10 25 20 26 24 38 79 57 37 14
2020/2021423 24 28 59 46 36 8 19 49 13 28 53 60
2021/2022261 22 28 0 5 6 3 17 16 2 34 102 26
2022/2023357 32 49 5 42 39 68 3 35 44 6 26 8
2023/2024207 20 17 9 9 53 79 0 5 15 0 0 0
Totale 1.593